A novel means to demonstrate early efficacy of a product in systemic lupus erythematosus.
Strand
Vibeke
V
Division of Immunology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA. vstrand@stanford.edu
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic